ABCELLERA BIOLOGICS Free Cash Flow Generation Index

Latest as of June 2026: 0.92x

ABCELLERA BIOLOGICS free cash flow generation index. ABCELLERA BIOLOGICS (8QQ) has a Free Cash Flow Generation Index of 0.92x as of June 2026. Free cash flow of €23.79 Million represents 1% of operating cash flow (€25.92 Million).

FCF Generation Index

0.92x
Free Cash Flow / Operating CF

Free Cash Flow

€23.79 Million
EUR

Operating Cash Flow

€25.92 Million
EUR

Capital Expenditures

€2.13 Million
EUR

Free Cash Flow Generation Index of ABCELLERA BIOLOGICS (2021–2022)

Free cash flow generation index of ABCELLERA BIOLOGICS from 2021 to 2022. Historical FCF Generation Index trend for ABCELLERA BIOLOGICS across 2 annual periods. See financial agility of ABCELLERA BIOLOGICS to measure the company's free cash flow as a share of total liabilities.

ABCELLERA BIOLOGICS Free Cash Flow Generation Index by Year (2021–2022)

ABCELLERA BIOLOGICS free cash flow generation index by year from 2021 to 2022. Year-by-year Free Cash Flow Generation Index for ABCELLERA BIOLOGICS. For the full cash flow conversion analysis, see ABCELLERA BIOLOGICS cash conversion from operations.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2022 0.74x €204.70 Million €277.36 Million €72.66 Million ▼ -3.0%
2021 0.76x €186.13 Million €244.58 Million €58.45 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).